White Paper

White Paper

Dose Optimization in Oncology: What is Your Strategy?

December 17, 2024
White Paper

Accelerated Approvals (AA): Not so Fast!

January 24, 2024
White Paper

Why Do So Many Phase III Fail?

December 12, 2022
White Paper

Randomized Clinical Trials: Impact of COVID-19

May 14, 2020
White Paper

IDDI Comments on FDA Draft Guidance on Expansion Cohorts

November 27, 2018

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now